Cephalosporins are barely mentioned in the HPA's guidance on treating infection and there is rising concern over their role in the development of C. difficile. Angus Thompson argues that, with suitable alternatives available, there is little reason to continue prescribing them.
History
Publication title
Prescriber
Volume
19
Issue
23-24
Pagination
24-27
ISSN
0959-6682
Department/School
School of Pharmacy and Pharmacology
Publisher
Wiley
Place of publication
UK
Rights statement
The definitive published version is available online at: http://interscience.wiley.com